Submission Details
| 510(k) Number | K963282 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 21, 1996 |
| Decision Date | January 22, 1997 |
| Days to Decision | 154 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K963282 is an FDA 510(k) clearance for the SERAQUEST HSV IGG, a Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific (Class II — Special Controls, product code LGC), submitted by Quest Intl., Inc. (North Miami, US). The FDA issued a Cleared decision on January 22, 1997, 154 days after receiving the submission on August 21, 1996. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3305.
| 510(k) Number | K963282 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 21, 1996 |
| Decision Date | January 22, 1997 |
| Days to Decision | 154 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LGC — Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3305 |